title: [Vedolizumab in Crohn Disease genesis-sefh drug evaluation report].
authors.affiliation: Hospital Regional Universitario de Málaga, Málaga.. rocio.asensi.sspa@juntadeandalucia.es.
authors.forename: Jenifer
authors.initials: J
authors.lastname: González Chávez
authors.affiliation: Hospital Regional Universitario de Málaga, Málaga.. rocio.asensi.sspa@juntadeandalucia.es.
authors.forename: Rocio
authors.initials: R
authors.lastname: Asensi Diez
authors.affiliation: Hospital Regional Universitario de Málaga, Málaga.. rocio.asensi.sspa@juntadeandalucia.es.
authors.forename: Rocío
authors.initials: R
authors.lastname: Tamayo Bermejo
authors.affiliation: Hospital Universitario de Puerto Real, Cádiz.. rocio.asensi.sspa@juntadeandalucia.es.
authors.forename: Emilio Jesús
authors.initials: EJ
authors.lastname: Alegre Del Rey
authors.affiliation: Hospital de Meixoeiro, Vigo. Spain.. rocio.asensi.sspa@juntadeandalucia.es.
authors.forename: Noemí
authors.initials: N
authors.lastname: Martínez López de Castro
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000191:economics / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy* / Q000191:economics; D004341:Drug Evaluation; D006801:Humans; D007166:Immunosuppressive Agents / Q000191:economics / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; C543529:vedolizumab